WARMINSTER, PA, August 18, 2026 /24-7PressRelease/ -- Kelly A. Boyle, MPM, has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Ms. Boyle has established herself as a distinguished biopharma project, portfolio and operations leader, recognized for her expertise in project and resource management. In her most recent capacity since 2025, she has led cross-functional planning, forecasting, and operational decision-making across product development and chemistry, manufacturing, and controls organizations within the pharmaceutical and biopharmaceutical sector. Ms. Boyle's leadership has been instrumental in directing capacity planning, resource forecasting and comprehensive project support for end-to-end product development, thereby strengthening both planning and portfolio decision-making.
From 2010 to 2025, Ms. Boyle served at Johnson & Johnson in two significant roles. As a senior manager of capacity management for nearly 10 years, she supported the chemistry, manufacturing, and controls organization with resource planning and analytics for demand and supply. She developed options to close gaps in delivering the portfolio while providing senior leadership with data-driven insights to inform critical decisions. In her earlier role as senior manager of program coordination within the immunology division, Ms. Boyle focused on cross-functional project management supporting programs such as Stelara and Tremfya.
During her tenure at Johnson & Johnson, Ms. Boyle collaborated closely with subject matter experts and senior leadership in the chemistry, manufacturing and controls biologics organization. She assessed project plans alongside an algorithmic model that automated resource-need forecasting, a model that had not been updated for several years prior to her involvement. Through diligent work with operational leads and subject matter experts, Ms. Boyle revamped the algorithms to better align with organizational changes by shifting from clinical milestones to chemistry, manufacturing and controls stage gates. This transformation simplified objective drivers while reducing reliance on manual overrides that previously hindered performance.
Over approximately two years, Ms. Boyle's initiative translated strategy into operational planning by making complex technical requirements comprehensible for all stakeholders. Her efforts resulted in a robust forecasting model that reduced forecast-versus-actual time reporting variance for about 75% of the organization from more than 20% to less than 5%. This achievement paved the way for subsequent advancements, such as machine learning integration and hands-free forecasting, further minimizing subjective input while enhancing accuracy.
Between 2007 and 2010 at Merck & Co., Ms. Boyle held the position of business analyst within the global clinical supplies organization as well as other project planning roles supporting several early and late development projects. She leveraged her scientific background to bridge laboratory research with business execution, collaborating closely with an inspirational project manager who had attended graduate school with her at the University of North Carolina at Chapel Hill. Their partnership provided valuable insights into maintaining scientific integrity while translating it into effective business prioritization and data driven decisions.
Employed by Merck & Co. for over a decade, Ms. Boyle first joined the pharmaceutical giant upon graduation from the University of North Carolina at Chapel Hill in 1999, where she advanced through drug development and laboratory leadership positions after beginning her career as a chemist in pre-formulation and formulation development. Initially specializing in inorganic chemistry before transitioning to organic chemistry due to curriculum requirements, she maintained a deep appreciation for inorganic chemistry, particularly transition metals, which influenced her work in pharmaceutical research. All of her six adopted beagles were named after transition metals.
Ms. Boyle earned a Bachelor of Science in chemistry with a minor in physics from Seton Hall University in New Jersey in 1997, where she was a member of the Division I softball team all four years and received the Female Scholar Athlete Award; a Master of Science in organic chemistry from the University of North Carolina at Chapel Hill in 1999; a Master of Education in Instructional Leadership from Neumann University in Aston Pennsylvania in 2006; and a Master of Project Management from the Pennsylvania State University in University Park in 2010. Each degree contributed foundational knowledge that enabled her success across scientific research, instructional leadership and advanced project management roles. Additionally, Ms. Boyle has demonstrated exceptional proficiency in project management principles with the completion of the project management professional certification from the Project Management Institute, earned in 2008.
Ms. Boyle's professional affiliations include membership with the Project Management Institute, the American Chemical Society and the American Association of Pharmaceutical Scientists, reflecting her commitment to ongoing professional development within the industry. Her dedication extends beyond professional pursuits through civic engagement as a supporter of pride groups, an advocate for neurodiversity organizations, a supporter of parents with children on the spectrum, volunteering to coach girls softball from grade school through college and volunteering to assist with the local grade school science program.
Throughout her career journey spanning more than two decades across leading pharmaceutical organizations, Ms. Boyle's achievements have been recognized through accolades, including several Top Performer Awards within the pharmaceutical industry. She attributes her achievements to the teachings, guidance and love imparted by her father, whose wisdom continues to influence her approach to challenges both professionally and personally. Known for her strong work ethic and focus when pursuing goals, Ms. Boyle draws inspiration from life lessons learned during childhood, which she now passes on to her own children and grandson.
Ms. Boyle's career is marked by innovation, integrity and academic excellence, as well as a passion for advancing science through effective leadership in biopharmaceutical development. Looking ahead, she aspires to lead a project management organization or hold an executive position where she can further enhance connections between strategy and operations while dedicating herself to teaching future generations of project managers, scientists and leaders, empowering them to thrive within their chosen fields.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. The suite of Marquis® publications, including Who's Who in America® and Who's Who in the World®, remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the globe. Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #